Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sabatier

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Molecular Pharmacology|January 16, 2003
Maurotoxin: a potent inhibitor of intermediate conductance Ca2+-activated potassium channelsN A Castle, D O London, C Creech, et al.
Annales De Dermatologie Et De Venereologie|February 3, 2016
[Lethal Lyell's syndrome induced by fusidic acid]C Cluzel, P Pralong, S Logerot, et al.
Biosensors & Bioelectronics|August 14, 2012
Peptide binding to ochratoxin A mycotoxin: a new approach in conception of biosensorsI Bazin, N Andreotti, A Ibn Hadj Hassine, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|January 11, 2001
Ion channel activation by SPC3, a peptide derived from the HIV-1 gp120 V3 loopE Carlier, K Mabrouk, M Moulard, et al.
The American Journal of Cardiology|April 1, 1992
Early hemodynamic results of left ventricular reconstructive surgery for anterior wall left ventricular aneurysmM Di Donato, G Barletta, M Maioli, et al.
Journal of Virology|February 1, 1991
Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1J M Sabatier, E Vives, K Mabrouk, et al.
FEBS Letters|March 15, 1993
Cytotoxic effect on lymphocytes of Tat from human immunodeficiency virus (HIV-1)A Benjouad, K Mabrouk, M Moulard, et al.
Blood|July 1, 1990
Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infectionE Bahraoui, A Benjouad, J M Sabatier, et al.
Proteins|November 20, 1997
Solution structure of maurotoxin, a scorpion toxin from Scorpio maurus, with high affinity for voltage-gated potassium channelsE Blanc, J M Sabatier, R Kharrat, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1985
[Transluminal coronary angioplasty. Experience apropos of 155 procedures]R Schmitt, M Sabatier, R Ratovo, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Molecular Pharmacology|January 16, 2003
Maurotoxin: a potent inhibitor of intermediate conductance Ca2+-activated potassium channelsN A Castle, D O London, C Creech, et al.
Annales De Dermatologie Et De Venereologie|February 3, 2016
[Lethal Lyell's syndrome induced by fusidic acid]C Cluzel, P Pralong, S Logerot, et al.
Biosensors & Bioelectronics|August 14, 2012
Peptide binding to ochratoxin A mycotoxin: a new approach in conception of biosensorsI Bazin, N Andreotti, A Ibn Hadj Hassine, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|January 11, 2001
Ion channel activation by SPC3, a peptide derived from the HIV-1 gp120 V3 loopE Carlier, K Mabrouk, M Moulard, et al.
The American Journal of Cardiology|April 1, 1992
Early hemodynamic results of left ventricular reconstructive surgery for anterior wall left ventricular aneurysmM Di Donato, G Barletta, M Maioli, et al.
Journal of Virology|February 1, 1991
Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1J M Sabatier, E Vives, K Mabrouk, et al.
FEBS Letters|March 15, 1993
Cytotoxic effect on lymphocytes of Tat from human immunodeficiency virus (HIV-1)A Benjouad, K Mabrouk, M Moulard, et al.
Blood|July 1, 1990
Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infectionE Bahraoui, A Benjouad, J M Sabatier, et al.
Proteins|November 20, 1997
Solution structure of maurotoxin, a scorpion toxin from Scorpio maurus, with high affinity for voltage-gated potassium channelsE Blanc, J M Sabatier, R Kharrat, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1985
[Transluminal coronary angioplasty. Experience apropos of 155 procedures]R Schmitt, M Sabatier, R Ratovo, et al.
Pageof 14